Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Respiratorisk syncytialvirus

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Svær adenoviruspneumoni hos en immunkompetent mand

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Allergisk kontakteksem ved anvendelse af insulinpumper og glukosesensorer hos børn med diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Remdesivir til behandling af COVID-19-pneumoni

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Stilheden før stormen - om psykiatrisk sygdom i coronaens tid

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Varicocele Testis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Bacille Calmette-Guérin vaccination at birth and differential white blood cell count in infancy. A randomised clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Short individualised treatment of bone and joint infections in Danish children

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Respiratory syncytial virus (RSV) is the most common pathogen of the lower respiratory tract in infants. Groups at risk for severe disease include preterm infants, infants with pulmonary disease such as bronchopulmonary dysplasia, infants with congenital heart disease, and infants suffering from immunodeficiency. However, most infants getting severely ill from RSV are otherwise healthy and born at term. The incidence of hospitalisation caused by RSV is increasing, and there is an association between diagnosed RSV infection and subsequent development of wheeze and asthma. No vaccine or causal therapy is available. However, prophylaxis with a humanized monoclonal antibody of murine origin, palivizumab, reduces the risk of hospitalisation in high-risk infants, but the treatment is expensive. The most important prophylaxis methods at the present time are therefore hygienic measures with the purpose of preventing nosocomial infection in hospitals.

Bidragets oversatte titelRespiratory syncytial virus
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind164
Udgave nummer48
Sider (fra-til)5623-6
ISSN0041-5782
StatusUdgivet - 25 nov. 2002

    Forskningsområder

  • Cross Infection/prevention & control, Humans, Infant, Infant, Newborn, Respiratory Syncytial Virus Infections/immunology, Risk Factors

ID: 55075978